COVID-19 Pandemic and the Impact on SEA Pharmaceutical Market
May 11, 2020
2:00PM - 3:30PM (GMT+08:00) Singapore Standard Time

COVID-19 has created immediate and long-term consequences for people and systems around Southeast Asia. IQVIA is committed to helping everyone in healthcare do what needs to keep things moving forward in this new reality.

As we continue to monitor the impact of COVID-19, IQVIA launches a whitepaper as its initial thinking, based on early data, on how COVID-19 is currently impacting the healthcare environment in Southeast Asia.

In SEA, post-launch points of impact for healthcare systems and the life sciences industry are emerging as six (6) key macro trends: fluctuating demand for health products, unpredictability in the supply chain, decline of healthcare services utilization, changing ways-of-working within the industry, falling private investment, and reactive equity market.

Join us to learn about how COVID-19 is shaping the healthcare in our region and understand the trends, challenges, and opportunities it presents for our industry.